Peptides, Pseudomonas aeruginosa, polysaccharides and lipopolysaccharides - Players in the predicament of cystic fibrosis patients: Response

Trends in Microbiology

Volumn 8, Issue 6, 2000, Pages 250-251

  Ernst, Robert K ^a   Miller, Samuel I ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; LIPID A; LIPOPOLYSACCHARIDE; POLYSACCHARIDE;

ACYLATION; ANTIBIOTIC RESISTANCE; CHRONIC LUNG DISEASE; CYSTIC FIBROSIS; HUMAN; LIPID ANALYSIS; LUNG INFECTION; MASS SPECTROMETRY; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SHORT SURVEY; STRAIN DIFFERENCE;

PSEUDOMONAS AERUGINOSA;

EID: 0034213191     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01744-3     Document Type: Letter

References (2)

1. R.K. Ernst Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa Science 286 1999 1561 1565
2. E.L. MacFarlane phoP – phoQ homologues in Pseudomonas aeruginosa regulate expression of the outer membrane protein OprH and polymyxin B resistance Mol. Microbiol. 34 1999 305 316